首页> 外文期刊>Gastrointestinal Endoscopy >Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures.
【24h】

Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures.

机译:内镜治疗采用多支架进行肝移植后非解剖性胆道狭窄。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Over the past decade, ERCP has become the preferred method of treatment for biliary strictures in patients after orthotopic liver transplantation (OLT). Although data strongly support ERCP for treating anastomotic strictures, the little information available for the role of ERCP in the treatment of nonanastomotic strictures (NAS) has been unpromising. OBJECTIVE: We investigated the efficacy and safety of using balloon dilation and multiple biliary stents to treat NAS. DESIGN: A retrospective study. SETTING: A tertiary-care medical center. PATIENTS: Fifteen patients who were diagnosed with post-OLT NAS between January 2003 and June 2007. INTERVENTIONS: ERCP with balloon dilation and multiple stenting. MAIN OUTCOME MEASUREMENTS: Resolution, complication, and recurrence rates. RESULTS: Eleven of the 15 patients completed endoscopic treatment, of whom 9 had cholangiographic improvement, biochemical normalization, and cholestatic symptom relief (treatment success), and 1 required retransplantation (treatment failure). None of the 9 successfully treated patients experienced NAS recurrence in a mean follow-up of 17 months. Of the remaining 4 patients, 1 died of nonbiliary causes and 3 were still undergoing treatment with stents in place, of whom 2 have near-normalized total serum bilirubin and were cholestatic symptom free. LIMITATIONS: A retrospective study, small sample size, single endoscopist. CONCLUSIONS: Endoscopic treatment of NAS with balloon dilation and multiple stents appears to be safe and effective, and it may reduce the need for retransplantation because of NAS. Larger studies are still required to confirm its utility as a mainstay for treating NAS and to determine what factors are associated with endoscopic treatment success.
机译:背景:在过去的十年中,ERCP已成为原位肝移植(OLT)后患者胆道狭窄的首选治疗方法。尽管数据强烈支持ERCP治疗吻合口狭窄,但是关于ERCP在非吻合口狭窄(NAS)治疗中的作用的可用信息很少。目的:我们研究了使用球囊扩张术和多个胆道支架治疗NAS的有效性和安全性。设计:一项回顾性研究。地点:三级医疗中心。患者:2003年1月至2007年6月之间,有15例被诊断为OLT后NAS的患者。干预措施:ERCP球囊扩张术和多次置入支架。主要观察指标:分辨率,并发症和复发率。结果:15例患者中有11例完成了内镜治疗,其中9例患者的胆管造影改善,生化正常化,胆汁淤积症状缓解(治疗成功),另外1例需要重新移植(治疗失败)。 9名成功治疗的患者中,没有人在平均17个月的随访中出现NAS复发。其余4例患者中,有1例死于非胆源性死亡,还有3例仍在接受支架治疗,其中2例总血清胆红素接近正常,且无胆汁淤积症状。局限性:回顾性研究,样本量小,内镜医师。结论:内镜下球囊扩张术和多支支架置入术治疗NAS是安全有效的,并且可以减少因NAS导致的再移植需求。仍需要更大的研究来确认其作为治疗NAS的主要手段并确定哪些因素与内窥镜治疗成功相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号